A detailed history of Aquatic Capital Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Aquatic Capital Management LLC holds 2,500 shares of DVAX stock, worth $32,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,500
Holding current value
$32,900
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.05 - $11.61 $25,125 - $29,025
2,500 New
2,500 $27,000
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $413,010 - $528,794
35,300 New
35,300 $438,000
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $740,704 - $878,414
58,600 New
58,600 $866,000
Q4 2022

Feb 14, 2023

BUY
$10.27 - $13.29 $71,890 - $93,030
7,000 Added 18.52%
44,800 $476,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $245,271 - $430,768
24,700 Added 188.55%
37,800 $395,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $12.83 $97,595 - $168,073
13,100 New
13,100 $165,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.66B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.